Renewed Research Efforts Needed To Understand Cardiovascular Disease In LMICs

The Lancet Global Health: Sustainable Development Goal 3 is unlikely to be achieved without renewed effort
Francesc Xavier Gómez-Olivé, field research manager at the University of the Witwatersrand, and Margaret Thorogood, honorary professor at the University of the Witwatersrand

“…Despite the social and economic burden of [cardiovascular disease deaths, including ischemic heart disease and stroke,] in [low- and middle-income] countries, research on the epidemiology, treatment, and risk markers for cardiovascular disease deaths has been scarce, preventing the development of essential evidence-based policies to address the burden. … Africa and India have a high prevalence of many cardiovascular risk factors associated with ischemic heart disease and stroke in high-income countries, such as tobacco use, diabetes, obesity, hypertension, and dyslipidemia. … Establishment of risk factor scores for cardiovascular disease in low-income and middle-income countries would help to unravel this issue, but development of such scores requires large cohorts and long follow-up to have a sufficient number of cardiovascular disease deaths. … These deaths could increase unless a new effort is implemented to better understand the risk factors and improve the diagnosis, treatment, and secondary prevention of cardiovascular disease in low-income and middle-income countries” (August 2018).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.